Literature DB >> 6292185

Internalization and degradation of receptor-bound human choriogonadotropin in Leydig tumor cells. Fate of the hormone subunits.

M Ascoli.   

Abstract

The studies presented herein were aimed at characterizing the pathway involved in the internalization and degradation of human choriogonadotropin by cultured Leydig tumor cells. A quick biochemical method that differentiates between the surface-bound and internalized hormone was developed. Using this method and two hormone derivatives labeled exclusively (with 125I) in the alpha or beta subunits, it was possible to follow the fate of each hormone subunit during hormone binding, internalization, and degradation. The results show that the hormone is internalized in the intact form and that it reaches its place of degradation (presumably the lysosomes) in the intact form. The pathway for degradation of the internalized hormone is complex, and it appears to involve processing of one or both subunits of the intact hormone, followed by subunit dissociation and further degradation of the individual subunits. The alpha subunit is quickly degraded by the cells. The only detectable degradation products are extracellular amino acids. The beta subunit is degraded slower, and several intracellular degradation products are detectable before amino acids appear in the medium.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292185

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Follicle-stimulating hormone (FSH) induced internalization of porcine FSH receptor in cultured porcine granulosa cells and Chinese hamster ovary cells transfected with recombinant porcine FSH receptor cDNA.

Authors:  C Zhu; H Tian; Z Xiong; H Xia
Journal:  J Tongji Med Univ       Date:  2001

2.  Measurement of occupied and non-occupied epidermal growth factor receptor sites in 216 human breast cancer biopsies.

Authors:  N Falette; M F Lefebvre; F Meggouh; M Eynard; E Garin; S Saez
Journal:  Breast Cancer Res Treat       Date:  1992-03       Impact factor: 4.872

3.  Evidence for the rapid internalization and recycling of lutropin receptors in rat testis Leydig cells.

Authors:  A D Habberfield; C J Dix; B A Cooke
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

4.  A constitutively active mutant of the human lutropin receptor (hLHR-L457R) escapes lysosomal targeting and degradation.

Authors:  Colette Galet; Mario Ascoli
Journal:  Mol Endocrinol       Date:  2006-06-27

5.  Epidermal growth factor stimulates tyrosine phosphorylation of phospholipase C-II independently of receptor internalization and extracellular calcium.

Authors:  M I Wahl; S Nishibe; P G Suh; S G Rhee; G Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

6.  Do agonists promote rapid internalization of beta-adrenergic receptors?

Authors:  L C Mahan; H J Motulsky; P A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

7.  A fresh look at augmenter of liver regeneration in rats.

Authors:  C R Gandhi; R Kuddus; V M Subbotin; J Prelich; N Murase; A S Rao; M A Nalesnik; S C Watkins; A DeLeo; M Trucco; T E Starzl
Journal:  Hepatology       Date:  1999-05       Impact factor: 17.425

8.  Dynamic kisspeptin receptor trafficking modulates kisspeptin-mediated calcium signaling.

Authors:  Le Min; Kathleen Soltis; Ana Claudia S Reis; Shuyun Xu; Wendy Kuohung; Manisha Jain; Rona S Carroll; Ursula B Kaiser
Journal:  Mol Endocrinol       Date:  2013-12-02

9.  Hepatic effects of endothelin. Receptor characterization and endothelin-induced signal transduction in hepatocytes.

Authors:  C R Gandhi; R H Behal; S A Harvey; T A Nouchi; M S Olson
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

10.  Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer.

Authors:  Shawn M Hillier; Kevin P Maresca; Frank J Femia; John C Marquis; Catherine A Foss; Nghi Nguyen; Craig N Zimmerman; John A Barrett; William C Eckelman; Martin G Pomper; John L Joyal; John W Babich
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.